Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

2.78CAD
17 Jul 2019
Change (% chg)

$-0.09 (-3.14%)
Prev Close
$2.87
Open
$2.88
Day's High
$2.89
Day's Low
$2.75
Volume
18,521
Avg. Vol
116,786
52-wk High
$4.94
52-wk Low
$2.25

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $206.99
Shares Outstanding(Mil.): 114.62
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.65 -- --
ROI: -- 8.96 14.49
ROE: -- 10.09 15.79

Earnings vs. Estimates